Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAVAS: Haemate HS for Bleeding During Aortic Valve Replacement
NCT00618293Phase 2Withdrawn
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Jan 2008
- Primary completion
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of factor viii + von Willebrand factor in Bleeding, sponsored by Heinrich Heine University Düsseldorf. Planned start Jan 2008; status: withdrawn.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
Bleeding
Beyond the preview
Go deeper on NCT00618293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618293.